Sangamo Therapeutics
SGMO
SGMO
210 hedge funds and large institutions have $919M invested in Sangamo Therapeutics in 2018 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 95 increasing their positions, 48 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
2.46% less ownership
Funds ownership: 66.25% → 63.79% (-2.5%)
15% less capital invested
Capital invested by funds: $1.09B → $919M (-$167M)
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
Holders
210
Holding in Top 10
2
Calls
$27.1M
Puts
$29.6M
Top Buyers
| 1 | +$21.9M | |
| 2 | +$21.4M | |
| 3 | +$19.8M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$17.3M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$13.5M |
Top Sellers
| 1 | -$13.2M | |
| 2 | -$7.02M | |
| 3 | -$6.1M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$5.83M |
| 5 |
Morgan Stanley
New York
|
-$4.62M |